8 Comments

Have you given any thought to CRON as a 3.0 contender? Gingko + Redwood + Altria is a very compelling framework for the "wear it, rub it on, stick it in, take a bubble bath in it" niches of 3.0. CGC as well, I suppose. But I've never really paid them much attention, so can't say for certain.

Expand full comment

Todd trying to send email and being blocked by Google service provider named AMG solutions founded by Josh Mudryk who is also investment firm called MUDZ INVESTING, he is website developer for Bulls on wall street stock alert services and has Bulls on Wall Street servers connected to the Brokerage TC2000. Emails pics to prove that they are working with RAGINGBULL who has charges filed against them for 137m in assets frozen

Expand full comment

While I try to figure out how and when to add to my 2.0 holdings, this is a very useful list to research. Thanks.

Expand full comment

INM aka M... ? 😁

Like their pipeline, including biosynthesis.

Aussies have interesting plays. I've chosen Auscann (AC8)

Not advice/do your own DD

position INM/AC8

Expand full comment

Separate question. Any thoughts on Zelira? $ZLD.au /position

Expand full comment

Will $XXII be a player in Cannabis 2.0 or 3.0?

22nd Century Group's primary mission in hemp/cannabis is to develop proprietary hemp/cannabis plants with valuable cannabinoid profiles and agronomic traits and to commercialize those plants through a synergistic portfolio of strategic partnerships in the hemp/cannabis industry.

Expand full comment

Hey Todd, a bit surprised to see $VBIO back on the list. :-) I have a position as well (a write off from 2019 that I never wrote off). Do you have any additional insight into their efforts to get back off of the grey market and back to a legit listing? I read their most recent release where they touch on hiring a firm to assist in that but wondering if you know anything further?

Expand full comment

Any opinion on FNNZF? Royalty play focused on private California companies.

Expand full comment